Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 18, 2007
Patent Application Number
10433108
Date Filed
November 29, 2001
Patent Citations Received
0
...
Patent Primary Examiner
Patent abstract
The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
